AI-Integrated Implantable Intraluminal Devices

Publication ID: 24-11857407_0003_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “AI-Integrated Implantable Intraluminal Devices,” Published Technical Disclosure No. 24-11857407_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857407_0003_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,407.

Summary of the Inventive Concept

This invention integrates AI, IoT, blockchain, and nanomaterials with implantable intraluminal devices to enhance fluid flow monitoring, optimize device performance, and improve patient outcomes.

Background and Problem Solved

The original patent described implantable intraluminal devices, but these devices lacked real-time monitoring capabilities, data security, and advanced materials. The new inventive concept addresses these limitations by integrating distinct technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The AI-integrated implantable intraluminal device system comprises a primary device with a first, elongate tubular member and an AI-powered sensor for monitoring fluid flow and detecting potential blockages. The system can be integrated with an IoT-enabled communication system for real-time flow data transmission to a remote monitoring station. Additionally, a blockchain-secured data storage system can be used to record and verify device performance data. The device can also feature a nanomaterial-enhanced membrane for improved biocompatibility and fluid flow. The system can be further enhanced with machine learning-based algorithms for predicting potential device failures and alerting medical professionals.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and nanomaterials with implantable intraluminal devices, which is not obvious from the original patent. The inventive step lies in combining these distinct technologies to create a more powerful system that enhances fluid flow monitoring, optimizes device performance, and improves patient outcomes.

Alternative Embodiments and Variations

Alternative embodiments could include integrating the device with other advanced technologies, such as augmented reality or 5G networks. Variations could include different nanomaterials or AI algorithms tailored to specific medical conditions or patient populations.

Potential Commercial Applications and Market

The AI-integrated implantable intraluminal device system has significant commercial potential in the medical device industry, particularly in the fields of cardiovascular and neurovascular medicine. The system's advanced features and improved patient outcomes could lead to increased market share and revenue growth.

CPC Classifications

Section	Class	Group
A	A61	A61F2/07
A	A61	A61F2/04
A	A61	A61F2/852
A	A61	A61F2/88
A	A61	A61F2/89
A	A61	A61F2002/041
A	A61	A61F2002/075
A	A61	A61F2240/001
A	A61	A61F2250/0065
Y	Y10	Y10T29/49826

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device engineering, specifically implantable intraluminal devices for vascular and organ interventions, requiring expertise in biomedical engineering, materials science, and medical device design with advanced knowledge of fluid dynamics, sensor integration, and minimally invasive medical technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with a graduate degree, 5-7 years of experience in medical device design, familiar with emerging technologies in sensor integration, data monitoring, and advanced materials for medical implants

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies into existing implantable medical device architectures represents a predictable extension of current medical monitoring trends. The source patent's fundamental design of a flexible tubular medical device provides a natural platform for incorporating advanced monitoring and communication technologies. The technical variations proposed in the PTD represent incremental improvements using well-established technological integration strategies common in medical device innovation.

Obvious Combinations & Variations

Source Patent Element

Helically arranged tubular member with fluid communication channels

PTD Variation

AI-powered sensor integrated into the tubular structure for fluid flow monitoring

Obviousness Reasoning

Adding sensors to medical devices is a known technique for enhancing diagnostic capabilities, with predictable results of improved patient monitoring

Source Patent Element

Flexible membrane design allowing fluid communication

PTD Variation

Nanomaterial-enhanced membrane for improved biocompatibility

Obviousness Reasoning

Material enhancement using nanomaterials is a standard approach in medical device design to improve performance characteristics

Source Patent Element

Implantable device with structural flexibility

PTD Variation

IoT-enabled communication system for real-time data transmission

Obviousness Reasoning

Integrating wireless communication with medical implants is a predictable technological progression with finite, known implementation strategies

Source Patent Element

Medical device with fluid flow channels

PTD Variation

Blockchain-secured data storage for device performance verification

Obviousness Reasoning

Implementing secure data tracking is an obvious extension of existing medical record-keeping technologies

Source Patent Element

Implantable tubular medical device

PTD Variation

Machine learning algorithms for predicting potential device failures

Obviousness Reasoning

Applying predictive analytics to medical device performance monitoring represents a standard technological enhancement with predictable results

35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed in this Published Technical Disclosure would be considered obvious to a Person Having Ordinary Skill In The Art in view of US Patent 11857407, as the proposed technological integrations represent predictable combinations of known techniques in medical device design, sensor integration, and data monitoring technologies, without requiring inventive complexity beyond the capabilities of an ordinarily skilled practitioner in the field.

Original Patent Information

Patent Number	US 11,857,407
Title	Implantable intraluminal device
Assignee(s)	W. L. Gore & Associates, Inc.